Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Metformin-d6 hydrochloride
Cat. No.:
OB0225LY-0342
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Metformin-d6 hydrochloride is a heavy hydrogen-labeled metformin that is commonly used in metabolic studies.
Synonym:
1,1-Dimethylbiguanide-d6 hydrochloride; 1185166-01-1; Metformin-d6 (hydrochloride); Metformin D6 Hydrochloride; Metformin-d6-hydrochloride; 3-(Diaminomethylidene)-1,1-bis(trideuteriomethyl)guanidine, hydrochloride; 1,1-Di(methyl-d3)biguanide hydrochloride
CAS No.:
1185166-01-1
Compound CID:
45039707
Formula:
C4H12ClN5
Formula Weight:
171.66
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Metformin-d6 hydrochloride can be used in metabolic disorders and diabetes research to explore its effects on insulin sensitivity and metabolic pathways.
Library Information
Targets:
AMPK
Pathways:
Autophagy; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-5
Plate Location:
d6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
30 mg/mL; 174.76 mM
Water Max Solubility:
30 mg/mL; 174.76 mM
